About: Neurotech International Limited, a clinical-stage biopharmaceutical development company, focuses on development of solutions for paediatric neurological disorders with a broad-spectrum oral cannabinoid drug therapy in Australia. The company develops NTI164 to treat autism spectrum disorder, paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections, paediatric acute-onset neuropsychiatric syndrome, and Rett syndrome. It also engages in executing medical research projects; and developing technological devices. The company conducts clinical studies to assess the neuro-protective, anti-inflammatory, and neuro-modulatory activities of its proprietary cannabis strains. The company has a collaboration with The University of Sydney. Neurotech International Limited was incorporated in 2016 and is based in Melbourne, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.01 (-3.45%)
NTI ASX Neurotech International Ltd
Neurotech International Ltd share price
NTI price activity
Último preço
$ 0,010
Variação (24h)
-0,00 AUD (-3,45%)
Volume
2.45M
Volume (média 4 sem.)
-
Abertura
$ 0,02
Variação do dia
$ 0,01 - $ 0,02
Fechamento anterior
$ 0,01
Último negócio
05 Oct, 5:10 am GMT+0
Atrasado
05 Oct, 5:10 am GMT+0
NTI price performance
Atrasado
05 Oct, 5:10 am GMT+0
quote.marketSignals